Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination

Antiviral Research

Volumn 100, Issue 1, 2013, Pages 84-89

  Cliquet, Florence ^a   Robardet, Emmanuelle ^a   Picard Meyer, Evelyne ^a  

^a WHO Coll Cent for Research and Management in Zoonoses Control   (France)

Author keywords

Nucleotide mutation; Oral vaccination; Phylogeny; Rabies vaccine; Sequencing

Indexed keywords

LIVE VACCINE; RABIES VACCINE; RECOMBINANT VACCINE; SAD B 19; SAD BERN 09 99; UNCLASSIFIED DRUG; VACCINE A; VACCINIA RABIES GLYCOPROTEIN RECOMBINANT VIRUS VACCINE; GLYCOPROTEIN; NUCLEOPROTEIN; PHOSPHOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG EFFICACY; EUROPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RABIES; VACCINATION; VECTOR CONTROL; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE; VULPES VULPES; WILDLIFE; ANIMAL; ANIMAL DISEASE; CLASSIFICATION; EC; EDQM; ERA; EUROPEAN COMMISSION; EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES & HEALTHCARE; EVELYN ROKITNICKI ABELSETH; GENETICS; IMMUNOLOGY; MATRIX; MOLECULAR GENETICS; NUCLEOTIDE MUTATION; OIE; ORAL DRUG ADMINISTRATION; ORAL RABIES VACCINATION; ORAL VACCINATION; ORV; P; RABIES VIRUS; RNA-DEPENDENT RNA POLYMERASE; RV; SAD; SEQUENCING; STREET ALABAMA DUFFERIN; V-RG; VACCINIA GLYCOPROTEIN RECOMBINANT; VIROLOGY; WILD ANIMAL; WORLD HEALTH ORGANIZATION; WORLD ORGANIZATION FOR ANIMAL HEALTH;

CANIDAE; RABIES VIRUS; VULPES; VULPES VULPES;

EC; EDQM; ERA; EUROPEAN COMMISSION; EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES & HEALTHCARE; EVELYN ROKITNICKI ABELSETH; GLYCOPROTEIN; MATRIX; NUCLEOPROTEIN; NUCLEOTIDE MUTATION; OIE; ORAL RABIES VACCINATION; ORAL VACCINATION; ORV; P; PHOSPHOPROTEIN; PHYLOGENY; RABIES VACCINE; RABIES VIRUS; RNA-DEPENDENT RNA POLYMERASE; RV; SAD; SEQUENCING; STREET ALABAMA DUFFERIN; V-RG; VACCINIA GLYCOPROTEIN RECOMBINANT; WHO; WORLD HEALTH ORGANIZATION; WORLD ORGANIZATION FOR ANIMAL HEALTH;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, WILD; EUROPE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINES, ATTENUATED;

EID: 84881508379     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.07.012     Document Type: Article

References (38)

1. Anonymous The oral vaccination of foxes against rabies 2002 Report of the Scientific Committee on Animal Health and Animal Welfare European Commission p. 55
2. M. Aubert Epidemiology of fox rabies L. Bögel, F.X. Meslin, M. Kaplan, Wildlife Rabies Control 1992 Wells Medical Ltd Kent 9 18
3. H. Badrane, C. Bahloul, P. Perrin, and N. Tordo Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity J. Virol. 75 2001 3268 3276
4. S.L. Baldauf Phylogeny for the faint of heart: a tutorial Trends Genet. 19 2003 345 351
5. A. Beckert, L. Geue, A. Vos, A. Neubert, C. Freuling, and T. Muller Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19 Microbiol. Immunol. 53 2009 16 21
6. J. Bingham, C.M. Foggin, H. Gerber, F.W. Hill, A. Kappeler, A.A. King, B.D. Perry, and A.I. Wandeler Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus) Vet. Rec. 131 1992 55 56
7. J. Blancou Ecology and epidemiology of fox rabies Rev. Infect. Dis. 10 1988 S606 S609
8. J. Blancou Rabies in Europe and the Mediterranean basin: from antiquity to the 19th century A.A. King, M. Aubert, A.I. Wandeler, Historical Perspective of Rabies in Europe and the Mediterranean Basin 2004 OIE Paris 15 24
9. F. Cliquet, and M. Aubert Elimination of terrestrial rabies in Western European countries Dev. Biol. 119 2004 185 204
10. European Pharmacopoeia Rabies vaccine (Live, Oral) for foxes seventh ed. European Pharmacopoeia, Europe General Notices Apply to All Monographs and Other Text 2011 EDQM Strasbourg 936 937
11. European Pharmacopoeia Vaccines for veterinary use. European Pharmacopoeia. General notices apply to all monographs and other texts seventh ed. 2011 EDQM Strasbourg pp. 590-595
12. M. Faber, M.L. Faber, A. Papaneri, M. Bette, E. Weihe, B. Dietzschold, and M.J. Schnell A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity J. Virol. 79 2005 14141 14148
13. C. Fehlner-Gardiner, S. Nadin-Davis, J. Armstrong, F. Muldoon, P. Bachmann, and A. Wandeler ERA vaccine-derived cases of rabies in wildilfe and domestic animals in Ontario, Canada, 1989-2004 J. Wildl. Dis. 44 2008 71 85
14. S. Finke, A. Karger, C. Freuling, and T. Muller Assessment of inactivated human rabies vaccines: biochemical characterization and genetic identification of virus strains Vaccine 30 2012 3603 3609
15. L. Geue, S. Schares, C. Schnick, J. Kliemt, A. Beckert, C. Freuling, F.J. Conraths, B. Hoffmann, R. Zanoni, D. Marston, L. McElhinney, N. Johnson, A.R. Fooks, N. Tordo, and T. Muller Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife Vaccine 26 2008 3227 3235
16. T.A. Hall BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT Nucleic Acids Symp. Series 41 1999 95 98
17. ICTV (2011) ICTV Official taxonomy: updates since the 8th report. Vertebrate. < http://talk.ictvonline.org/files/ictv-official-taxonomy- updates-since-the-8th-report/m/vertebrate-official/4188.aspx > (accessed 30.04.13.).
18. M.P. Kieny, R. Lathe, R. Drillien, D. Spehner, S. Skory, D. Schmitt, T. Wiktor, H. Koprowski, and J.P. Lecocq Expression of rabies virus glycoprotein from a recombinant vaccinia virus Nature 312 1984 163 166
19. T. Kirandjiski, S. Mrenoski, I. Celms, D. Mitrov, I. Dzadzovski, I. Cvetkovikj, K. Krstevski, E. Picard-Meyer, P. Viviani, D. Malinovski, J.M. Demerson, A. Cvetkovikj, K. Davcheva, E. Nakova, S. Tomeska Mickova, and F. Cliquet First reported cases of rabies in the Republic of Macedonia Vet. Rec. 170 2012 312
20. S. Kwok, and R. Higuchi Avoiding false positives with PCR Nature 339 1989 237 238
21. F. Lafay, J. Benejean, C. Tuffereau, A. Flamand, and P. Coulon Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern Vaccine 12 1994 317 320
22. O. Matouch, J. Vitasek, Z. Semerad, and M. Malena Elimination of rabies in the Czech Republic Dev. Biol. 125 2006 141 143
23. T. Muller, H.J. Batza, A. Beckert, C. Bunzenthal, J.H. Cox, C.M. Freuling, A.R. Fooks, J. Frost, L. Geue, A. Hoeflechner, D. Marston, A. Neubert, L. Neubert, S. Revilla-Fernandez, E. Vanek, A. Vos, E. Wodak, K. Zimmer, and T.C. Mettenleiter Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria Arch. Virol. 154 2009 1081 1091
24. K.B. Nicholas, H.B. Nicholas, and D.W. Deerfield GeneDoc: analysis and visualization of genetic variation Embnew News 4 1997 14
25. P.P. Pastoret, A. Kappeler, and A. Aubert European rabies control and its history A.A. King, M. Aubert, A.I. Wandeler, Historical Perspective of Rabies in Europe and the Mediterranean Basin 2004 OIE Paris 337 350
26. Rabies Bulletin Europe Rabies Information System of the WHO Collaboration Centre for Rabies Surveillance and Research 2012 WHO Wusterhausen (Germany)
27. C.E. Rupprecht, K.M. Charlton, M. Artois, G.A. Casey, W.A. Webster, J.B. Campbell, K.F. Lawson, and L.G. Schneider Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis) J. Wildl. Dis. 26 1990 99 102
28. L.G. Schneider, and J.H. Cox Ein Fedelversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland Tierärztl. Umsch. 38 1983 315 324
29. L.G. Schneider, J.H. Cox, and W.W. Müller Der Feldversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland (BRD) Eine Zwischenbilanz. Tierärztl. Umsch. 42 1987 184 198
30. A. Servat, and F. Cliquet Official batch control of rabies veterinary vaccines: current situation and perspectives in the European Union Altern. Lab. Anim. 41 2013 10 11
31. F. Steck, A. Wandeler, and P. Bichsel Oral immunization of foxes against rabies. Laboratory and field studies Comp. Immunol. Microbiol. Infect. Dis. 5 1982 165 171
32. K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods Mol. Biol. Evol. 28 2011 2731 2739
33. A. Vos, A. Neubert, O. Aylan, P. Schuster, E. Pommerening, T. Muller, and D.C. Chivatsi An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species Epidemiol. Infect. 123 1999 165 175
34. A.I. Wandeler Control of wildlife rabies J.B. Campbell, K.M. Charlton, Rabies 1988 Kluwer Academic Publishers Boston 365 380
35. WHO, 2013. WHO expert consultation on rabies - second report. WHO Technical Report Series 982, p. 139.
36. T.J. Wiktor, R.I. Macfarlan, K.J. Reagan, B. Dietzschold, P.J. Curtis, W.H. Wunner, M.P. Kieny, R. Lathe, J.P. Lecocq, and M. Mackett Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene Proc. Natl. Acad. Sci. USA 81 1984 7194 7198
37. World Health Organisation for Animal Health, 2012a. Principle of veterinary vaccine production. Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees), seventh ed. World Organization for Animal Health, Paris, pp. 52-63.
38. World Health Organisation for Animal Health, 2012b. Rabies. Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees), seventh ed. World Organization for Animal Health, Paris, pp. 263-282.